See the "Universal eyes greater gain on mine" thread,In short 'The DFS showed an estimated net present value of $282 million for Roseby, which equated to 82c per share. '
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%